- Home
- LGIH vs NKTR Comparison
LGIH vs NKTR Comparison
Compare LGIH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGIH | NKTR |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LGIH | NKTR |
|---|---|---|
| Price | $47.83 | $53.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $71.13 | ★ $106.33 |
| AVG Volume (30 Days) | 330.9K | ★ 613.8K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.53 | N/A |
| Revenue | ★ $1,788,933,000.00 | $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.77 | N/A |
| P/E Ratio | $10.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.70 | $6.48 |
| 52 Week High | $104.31 | $66.92 |
Technical Indicators
Market Signals| Indicator | LGIH | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.65 | 44.41 |
| Support Level | $46.73 | $50.49 |
| Resistance Level | $50.54 | $59.23 |
| Average True Range (ATR) | 2.17 | 3.97 |
| MACD | -0.36 | -0.70 |
| Stochastic Oscillator | 10.77 | 18.26 |
Price Performance
Historical ComparisonAbout LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.